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ABSTRACT
The Notch signaling pathway plays a crucial role in specify-
ing cellular fate in metazoan development by regulating
communication between adjacent cells. Correlative studies
suggested an involvement of Notch in hematopoietic cell
development. Here, we report that the Notch pathway is
expressed and active in microglial cells. During inﬂamma-
tory activation, the transcription of the Notch down-stream
effector Hes1 is downregulated. When Notch1 transcription
in microglia is inhibited, an upregulation of the expression
of pro-inﬂammatory cytokines is observed. Notch stimula-
tion in activated microglia, using a soluble form of its
ligand Jagged1, induces a decrease in pro-inﬂammatory
cytokines secretion and nitric oxide production as well as
an increase in phagocytic activity. Notch-stimulation is
accompanied by an increase in the rate of STAT3 phospho-
rylation and nuclear translocation. Our results show that
the Notch pathway plays an important role in the control of
inﬂammatory reactions in the CNS. VC 2007 Wiley-Liss, Inc.
INTRODUCTION
Microglia, the CNS-resident cells of the myeloid cell
lineage, is the primary competent actor for the innate
as well as the adaptive immune response in the brain.
During embryogenesis, these cells invade the CNS tis-
sue and contribute to the removal of dead cells and
debris occurring during the shaping of the developing
brain. In the postnatal CNS, microglia acquires a highly
differentiated phenotype, characterized by a ramiﬁed
morphology. These cells are often referred to as quies-
cent or resting microglia, although they are active and
contribute to the brain homeostasis and the neuronal
survival (Kreutzberg, 1996; Nimmerjahn et al., 2005;
Streit et al., 2005).
Resting microglia is able to rapidly react to a wide
array of acute and chronic insults (Davalos et al., 2005;
Nimmerjahn et al., 2005). This activation process results
in a change in morphology, initiation of chemotaxis, and
a profound modiﬁcation of the transcription proﬁle.
Activated microglia is the source of numerous pro-
inﬂammatory products, such as chemokines, cytokines,
arachidonic acid derivates, reactive oxygen, and nitrogen
intermediates. Since such a microenvironment is likely
to be deleterious for the fragile neuronal network, pro-
inﬂammatory microgliosis is suspected to be profoundly
implicated, directly or indirectly, in the course of several
neurodegenerative diseases like Alzheimer’s disease
(Akiyama et al., 2000; Gao et al., 2003; Sastre et al.,
2006).
For the immune surveillance function, microglial cells,
like macrophages, rely on the expression of pattern-rec-
ognition receptors like the TLRs, scavenger-receptors,
Fc, and complement-receptors (Husemann et al., 2002;
Lee and Lee, 2002; McGeer et al., 2005). Signaling
through diffusible mediators, like cytokines, chemokines,
or arachidonic acid derivates, will help to adapt the cel-
lular response (Akiyama et al., 2000). Since microglial
cells are tightly integrated into a dense tissue, numer-
ous cellular contacts with neighboring cells are estab-
lished (Davalos et al., 2005; Nimmerjahn et al., 2005). It
thus seems likely that cell-contact mediated signaling
will also play an important role during the activation
process of microglial cells.
The Notch family of receptors regroups proteins with
a single transmembrane domain (Artavanis-Tsakonas
et al., 1999; Hansson et al., 2004). Four different Notch
receptor genes have been identiﬁed in mammals,
Notch1, 2, 3, and 4 (Mumm and Kopan, 2000). Five dif-
ferent Notch ligands, also showing a single transmem-
brane domain, have been identiﬁed: Jagged1 and 2,
Delta1, 3, and 4 (Hansson et al., 2004). Both receptors
and ligands exhibit epidermal growth factor-like extrac-
ellular repeats and interact via their Delta/Serrate/Lag
(DSL) domain located adjacent to the N-terminus of the
protein. Upon effective ligand binding, Notch receptors
undergo proteolytic cleavage releasing the intracellular
Notch receptor region/translocation-associated Notch
homologue-1, NICD (Notch IntraCellular Domain).
NICD is then translocated towards the nucleus, where it
associates with the transcription factor CBF1/Suppres-
sor of Hairless/LAG-1/RBP-Jk (CSL) (for review, Baron,
2003). In the absence of NICD, CSL is normally associated
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with corepressors, actively inhibiting transcription.
NICD will displace the corepressors, recruit coactivators,
and initiate CSL-dependent transcription. The most im-
portant known target genes are members of the Hes (ba-
sic helix-loop-helix Homolog Enhancers of Split) family
of transcription factors, including Hes1 and Hes5 (Ohishi
et al., 2003). Although some CSL-independent Notch sig-
naling can occur, its mechanism is not well character-
ized (Zlobin et al., 2000).
Signaling through the Notch receptors is involved in
the development of several cell types and the modula-
tion of these signals can markedly affect differentiation,
proliferation, and apoptotic events (Kimble and Simp-
son, 1997; Weinmaster, 1997). Activation of the pathway
has been shown to be an important fate decision signal
in different developmental contexts and has been associ-
ated with the proliferation of several somatic stem cell
lines, such as the neural and hematopoietic stem cells
(Shen et al., 2004; Varnum-Finney et al., 2000). A num-
ber of studies have implicated Notch signaling in lymph-
oid cell line commitment, thymic T cell development,
and myeloid cell differentiation (Izon et al., 2002;
Radtke et al., 1999; Washburn et al., 1997; Wolfer et al.,
2001). The role of Notch signaling is not conﬁned to the
developmental process but seems to play an important
role in the mature tissues. A modulatory role during
macrophage activation has been recently documented
(Monsalve et al., 2006). The stabilization of the neuronal
networks in the mature CNS appears to depend on
Notch signaling (Sestan et al., 1999). Demyelinating
lesions induce an upregulation of the expression of
Notch ligands (John et al., 2002).
Here, we provide evidence for a new role of Notch sig-
naling in the mature CNS. We show that microglia
express Notch receptors, and that this pathway is func-
tional. In addition, pro-inﬂammatory activations silence
Hes1 transcription in microglial cells. By decreasing
expression of Notch receptors, we succeed in enhancing
some pro-inﬂammatory parameters. On the other hand,
an activation of the signaling pathway by soluble
ligands reduces the inﬂammatory response of activated
microglia and stimulates phagocytosis. Our results show
that Notch activation modulates STAT3 phosphorylation
and nuclear translocation in activated microglia. Thus,
Notch signaling appears to be an instrument for the con-
trol of inﬂammatory reactions in the CNS.
MATERIAL AND METHODS
Cell Culture
For primary microglia, primary mixed glial cell cul-
tures were prepared from the brains of newborn Wistar
rat pups as previously described (Morga et al., 2000).
Brieﬂy, after carefully removing meninges and large
blood vessels, the brains were pooled and then minced
in cold phosphate-buffered salt solution. The dissociation
was completed by 10 min incubation in 1 mM EDTA and
passage through a nylon mesh (pore size, 100 lm). The
cells were allowed to attach and grow at 37C in DMEM
supplemented with 20% fetal calf serum, penicillin (100
U/mL), and streptomycin (100 lg/mL) in a water-satu-
rated atmosphere containing 5% CO2. After 4 days, the
cells were moved to 10% fetal calf serum-containing
DMEM, which was replaced twice a week. After 10–14
days, when the cultures reached conﬂuence, microglia
was detached by two 8 h shakings on a rotary shaker.
Microglial cells were then moved to 10% FCS-containing
DMEM. Primary microglia was activated with LPS at
0.001 lg/mL, since higher concentrations affect its cell
survival. For experiments requiring larger amounts of
material, the MMGT12 microglial cell line was used
(Figs. 2, 4, 5B,C, 6, 7). This cell line presents a behavior
comparable to that of primary microglia (Balboa et al.,
2001; Briers et al., 1994; Hemmer et al., 2001).
The murine microglial cell line MMGT12, a generous
gift from Dr. Vanmechelen, Innogenetics, Gent (Bel-
gium), was cultured in DMEM/Ham’s F12 (1/1), supple-
mented with 2% FCS (Invitrogen, Scotland), 1% ITS
(Insulin-Transferrin-Selenium, Invitrogen), and 15% ﬁl-
tered conditioned medium of WEHI cells (WEHI 3,
WEHI 3B, and WEHI 3D, ATCC, Rockville, MD). No
antibiotics were used. The cells were grown at 37C in a
water-saturated incubator at 5% CO2 and passaged
twice a week.
For experiments, MMGT12 microglial cells were
seeded into multiwell plates at a density of 104 cells/mL
in DMEM/F12, 10% FCS, and 1% ITS (experimental me-
dium). After 2 days of culture, cells were activated by
adding different stimuli to the culture medium as indi-
cated in the text: lipopolysaccharide (LPS; 0.01 lg/mL),
interferon-g (IFN-g; 100 U/mL), and tumor necrosis fac-
tor-a (TNF-a; 10 ng/mL).
Two types of soluble Jagged1 have been used. For the
experiments described in Figs. 5B,C and 7, we have
used conditioned medium enriched with a soluble form
of human Jagged1, produced from NIH-3T3 cells stably
transfected with the human Jagged1 extracellular do-
main (hJaggedEC-3T3 cells, a generous gift from Prof.
Artavanis-Tsakonas, Colle`ge de France, Paris, France
and Harvard Medical School, Boston, USA) (Sestan et
al., 1999). hJaggedEC-3T3 cells and untransfected 3T3
cells (used as control) were treated as described (Grand-
barbe et al., 2003). For the other experiments, 1 lg/mL
of recombinant rat Jagged1 (R&D Systems, UK) was
used as a tool for Notch activation. This concentration
was established by concentration-response experiments.
The results obtained, with the concentration of 1 lg/mL
of recombinant rat Jagged1, were the same as those
obtained with the soluble form of human Jagged1.
Treatment with Antisense Oligonucleotides
and Notch1 siRNA
The antisense oligonucleotides were designed against
the EGF repeat region of the Notch1 gene. Nonsense oli-
gonucleotides were used as a control and contained the
same ratio of base pairs found in the antisense oligonu-
cleotides but in a random order. The sequence for the
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antisense oligonucleotide was 50-GAA GTC ATT AAC
ACG CTG CAC AC, and for the nonsense oligonucleotide
50-TAC ATC AGC AGA CTA CAC GAG TC. The oligonu-
cleotides were puriﬁed by HPLC (Eurogentec, Belgium).
Microglial cells were treated with the oligonucleotides at
a ﬁnal concentration of 5 lM during 48 h.
Transfections with Notch1 siRNA (to a ﬁnal concen-
tration of 100 nM) were carried out in the six-well plates
on primary microglia using Lipofectamine 2000 (Invi-
trogen) for 48 h. Notch1-speciﬁc siRNA duplex was 50-
UUG AUG UCG AUC UCG CAG G and 50-CCU GCG
AGA UCG ACA UCA A, and siRNA negative control
duplex were ordered from Eurogentec.
RT-PCR Analysis
Total RNA was puriﬁed from cultured cells using the
SV Total RNA Isolation System (Promega, CA). RNA
analysis was performed with RNA electrophoresis Expe-
rion system (Biorad, CA) to check the quality of RNA
and to conﬁrm the absence of genomic contamination.
RNA was reverse transcribed using the ImProm-II
Reverse Transcription System (Promega) with 0.5 lg/
reaction oligo(dT) as primer and 1 lg of total RNA. The
RNA and oligo-dT were denaturated by preheating to
70C for 5 min followed by an immediate chill in ice
water for at least 5 min. The reverse transcription reac-
tion was performed in a total volume of 40 lL containing
ImProm-II 53 Reaction Buffer, 25 mM MgCl2, and 0.5
mM each of dATP, dTTP, dCTP, and dGTP for 1 h at
42C. For ampliﬁcation, speciﬁc oligonucleotide primer
pairs were incubated with 1 lL cDNA and 0.8 U Taq
DNA Polymerase in a 25 lL PCR Master Mix (Promega).
Typical cycle conditions were 30 s at 94C, 30 s at 55C,
and 1 min at 72C. Twenty microliter of the resulting
mix were then separated on a 2% agarose gel and
visualized by ethidium bromide staining on a transillu-
minator. The primers for RT-PCR analysis were as fol-
lows: mouse Notch1 50primer, TGC CAA ATG CCT GCC
AGA AT and 30primer, CAT GGA TCT TGT CCA TGC
AG; mouse Notch2 50primer, GAG GCG ACT CTT CTG
CTG TTG AAG A and 30primer ATA GAG TCA CTG
AGC TCT CGG ACA G; mouse Jagged1 50primer, TTA
CTG TGG GAC TCA TCA GC and 30primer TCA CAG
TTC TGA CCC ATC CA; mouse Hes1 50primer, CAG
CCA GTG TCA ACA CGA CAC and 30primer CTC GTT
CAT GCA CTC GCT GA; mouse TNF-a 50primer, CTC
CCT CCA GAA AAG ACA CC and 30primer TTT GGG
GAC CGA TCA CCC CG; mouse IL-1b 50primer, GAC
CCC AAA AGA TGA AGG GC and 30primer ATG AGT
CAC AGA GGA TGG GC; mouse IL-6 50primer, TGC
CTT CTT GGG ACT GAT GC and 30primer GCC TCC
GAC TTG TGA AGT GG; mouse b-actin 50primer, CGT
GGG CCG CCC TAG GCA CCA and 30primer TTG GCC
TTA GGG TTC AGG GGG G; rat Hes1 50primer, CAG
CCA GTG TCA ACA CGA CAC and 30primer CTC GTT
CAT GCA CTC GCT GA; rat TNF-a 50primer AGA ACT
CCA GGC GGT GTC TGT and 30primer CCT TGT CCC
TTG AAG AGA ACC; rat NOSII 50primer CTG CAT
GGA ACA GTA TAA GGC AAA C and 30primer GAG
ACA GTT TCT GGT CGA TGT CAT GA; rat IL-1b
50primer TGA CTC GTG GGA TGA TGA CG and
30primer ACC AGT TGG GGA ACT GTG CA; rat IL-6
50primer CAT TCT GTC TCG AGC CCA CC and
30primer GCC TCC GAC TTG TGA AGT GG and rat b-
actin 50primer, TCA CCG AGG CCC CTC TGA ACC
CTA and 30primer GGC AGT AAT CTC CTT CTG CAT
CCT. ‘‘in silico’’ PCR AmpliﬁX 1.37 software was used to
test our primers.
Real-Time RT-PCR
mRNA gene expression levels were determined after
reverse transcription by real-time PCR by using a iQ5
Bio-Rad iCycler System (Bio-Rad, CA, USA). For the
genes listed below, the relative expression was deter-
mined by using the SYBR Green PCR kit (Bio-Rad).
Primer sequences designed using Beacon Designer soft-
ware (Bio-Rad) were as follows: mouse Notch1 50primer
GCA GGC AAG ATG TTA ATG AGT G and 30primer
AGG GCA CAT AGG GCA GTT C; mouse Hes1 50primer
GCC AAT TTG CCT TTC TCA TCC and 30primer GGT
GAC ACT GCG TTA GGA C; mouse b-actin 50primer
AGG GAA ATC GTG CGT GAC ATC AAA GAG and
30primer GGA GGA AGA GGA TGC GGC AGT GG; rat
Notch1 50primer CCG TGT GGC TTC CTT CTA C and
30primer GGT TGG TGT CGC AGT TGG; rat Hes1
50primer CCA ATT TGC TTT CCT CAT CCC and
30primer GAA GGC GAC ACT GCG TTA G; rat TNF-a
50primer GCT CTT CTG TCT ACT GAA CTT C and
30primer GAT CTG AGT GTG AGG GTC TG; rat IL-1b
50primer GTT GAA TCT ATA CCT GTC CTG TG and
30primer TGG TCT TGA CTT CTA TCT TGT TG; rat
IL-6 50primer AAT CTG CTC TGG TCT TCT GG and
30primer GTA TTG CTC TGA ATG ACT CTG G; rat b-
actin 50primer GCT GAG AGG GAA ATC GTG CGT
GAC and 30primer GGA GGA AGA GGA TGC GGC
AGT GG.
cDNA was synthesized from total RNA by reverse
transcriptase reaction by using ImProm-II Reverse
Transcription System (Promega) with 0.5 lg/reaction oli-
go(dT) as primer. cDNA synthesized from 1 lg of total
RNA from MMGT12 microglial cells or from 200 ng of
total RNA from primary microglia, was used as template
in each reaction. cDNA templates, measured with Nano-
Drop ND-1000 Spectrophotometer (NanoDrop, De, USA),
were used at similar concentrations. For standardization
of quantiﬁcation, b-actin was ampliﬁed simultaneously.
The change of reporter ﬂuorescence from each reaction
tube was monitored by iQ5 Real Time PCR Detection
System. The threshold cycle of each gene was deter-
mined as PCR cycles at which an increase in reporter
ﬂuorescence above a baseline signal was observed. The
difference in threshold cycles between the target gene
and reference gene (b-actin) gives the standardized
expression level (dCt). Subtraction of dCt of a deﬁned
control condition from dCt of different conditions gives
the ddCt value that was used to calculate relative
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expression levels of different conditions with the formula
22ddCt. The expression levels of each gene were ex-
pressed as normalized fold expression.
Each sample was tested in triplicate PCR wells, and
samples obtained from three independent experiments
were used to calculate the mean 6 SEM.
Immunostaining
Microglial cells were ﬁxed for 20 min in 4% parafor-
maldehyde in PBS (pH 7.4), washed in PBS and perme-
abilized 5 min with PBS/0.5% Triton X-100 (Sigma,
MO). The cells were incubated overnight at 4C in PBS
containing 3% BSA and the appropriate mixture of anti-
bodies. The primary antibody used was mouse monoclo-
nal anti-Notch1 (1/100, NEOMARKERS, CA). After
washing in PBS, the cells were incubated for 1 h with
Cy2-conjugated secondary antibodies (1/1,000, Jackson
ImmunoResearch, PA). Control staining for nonspeciﬁc
binding with an isotype-matched control antibody was
realized. Preparations were counterstained with DAPI
(1/1,000, Molecular Probes, OR), mounted in Fluoro-
mount-G (Southern Biotechnology Associates, AL) and
viewed for immunoﬂuorescence using a Leica ﬂuores-
cence microscope.
Immunoblotting
Cells were collected in phosphate buffered saline and
lysed by repeated freeze/thaw cycles. Protein content of
the lysates was determined with a microplate version of
the Lowry assay, using bovine serum albumin stand-
ards. The lysates were separated by SDS-PAGE and
blotted onto a supported nitrocellulose membrane. The
blots were incubated overnight with the monoclonal goat
anti-Notch1 antibody (C-20) (Santa Cruz Biotechnology,
CA). For revelation by chemiluminescence, a peroxy-
dase-conjugated AfﬁniPure Mouse Anti-Goat IgG
(Jackson ImmunoResearch, PA) and SuperSignal West
Femto Chemiluminescence Substrate (Pierce, IL) were
used.
Measurement of Phagocytosis
Five hundred microliter of cell suspension (density of
4 3 104 cells/mL) were seeded into 48-well microtiter
plates. After 48 h at 37C, Jagged1 was added at differ-
ent concentrations and incubated during 24 h. Yellow-
green FluoSpheres (1 lm, Molecular Probes) were resus-
pended in 25 mM NA2HPO4, pH 6.0 containing 3% BSA
and incubated at room temperature for 15 min with
bath sonication. Fifty microliter of the sonicated suspen-
sion (containing 100 3 106 microspheres) were added to
cultured microglia (105 cells/well; 1 mL of culture me-
dium/well). After 75 min at 37C, cells were washed
three times with PBS and ﬂuorescence was measured at
520 nm with a microplate reader (FLUOstar OPTIMA).
To differentiate between phagocytosed beads and beads
that nonspeciﬁcally adhered to the cell surface, control
cells were exposed to 0.3% azide for 10 min before the
addition of microspheres. This treatment compromises
microglial energetic processes and only a few beads are
internalized as observed by ﬂuorescent microscopy. The
ﬂuorescence of azide-treated MMGT12 microglial cells
was used as the negative control. Background ﬂuores-
cence of MMGT12 microglial cells cultured in the ab-
sence of ﬂuorescent microspheres was less than 10% of
the ﬂuorescence values obtained using azide-treated
MMGT12 microglial cells cultured in the presence of
microspheres.
In the same experiments, we conducted luminescent
cell viability assay to quantify the number of cells per
well. The CellTiter-Glo luminescent cell viability assay
(Promega) was used to determine the number of viable
cells in culture.
Nitric Oxide Release
NO production was measured 48 h after LPS induc-
tion. The release of NO radicals was estimated by meas-
uring the accumulation of nitrite in the culture superna-
tant by using the Griess reaction as previously described
(Morga et al., 1998).
Measurement of TNF-a and IL-6 Productions
TNF-a and IL-6 concentrations were measured using
the DuoSet ELISA/Assay Development kit from R&D
Systems (MN, USA). TNF-a and IL-6 productions were
measured in the culture supernatant 24 h after LPS
exposure.
STAT3 and NF-jB p65 Activation Assay
Activation of NF-jB p65 was determined using the
TransAM NF-jB p65 transcription factor assay (Active
Motif, CA) according to the manufacturer’s recommenda-
tions. Nuclear extracts were prepared from microglial
cells by hypotonic lysis. Nuclear lysates (10 lg of pro-
tein) were incubated in 96-well dishes containing immo-
bilized oligonucleotides containing a NF-jB consensus
DNA-binding site for 1 h at room temperature. Wells
were then washed three times, and 100 lL of NF-jB p65
monoclonal antibody (1/1,000) were added to each well
for 1 h at room temperature. Wells were washed three
times, and then 100 lL of horseradish peroxidase-conju-
gated secondary antibody (1/1,000) were added to each
well for 1 h at room temperature. Wells were washed
four times, and 100 lL of developing solution were
added to each well for 10 min at room temperature. Stop
solution (100 lL) was added to each well, and the ab-
sorbance at 450 nm was determined using an enzyme-
linked immunosorbent assay (ELISA) reader. Jurkat
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cells nuclear extracts were included as positive controls
for p65.
Activation of STAT3 was determined using the
TransAM STAT3 transcription factor assay (Active
Motif) according to the manufacturer’s recommenda-
tions. Nuclear extracts were prepared from microglial
cells by hypotonic lysis. Nuclear lysates (10 lg of pro-
tein) were incubated in 96-well dishes containing immo-
bilized oligonucleotides containing a STAT consensus
DNA-binding site for 1 h at room temperature. Wells
were then washed three times, and 100 lL of STAT3
monoclonal antibody (1/1,000) were added to each well
for 1 h at room temperature. Wells were washed three
times, and then 100 lL of horseradish peroxidase-conju-
gated secondary antibody (1/1,000) were added to each
well for 1 h at room temperature. Wells were washed
four times, and 100 lL of developing solution were
added to each well for 10 min at room temperature. Stop
solution (100 lL) was added to each well, and the ab-
sorbance at 450 nm was determined using an enzyme-
linked immunosorbent assay (ELISA) reader. Nuclear
extracts from HepG2 cells (treated with IL-6, 100 ng/
mL) were included as positive controls for STAT3.
Statistical Analysis
The data represent mean 6 SEM values from at least
three independent experiments. For nitrite, TNF-a, IL-
6, and STAT3 determinations, measurements were also
done in triplicates. For comparison of means, obtained
by ELISA, between two different treatments, statistical
analysis was done by Student’s t-test (two-sample
assuming unequal variances). For comparison of multi-
ple treatments, results were analyzed by an ANOVA
followed by a Fisher’s exact test.
RESULTS
The Notch Pathway is Expressed in Resting
and Activated Microglial Cells
Notch1 receptor expression was detected on microglial
cells in vitro. Primary microglial cells were stained with
antibodies against the ligand binding region of the
Notch1 receptor (Figs. 1A,B). All observed microglial
cells were positive for Notch1-staining. Notch1 receptor
is expressed in resting (Fig. 1A) and in LPS (0.001 lg/
mL) activated microglia (Fig. 1B). Activated microglia
appeared to be more intensively stained (Fig. 1B).
In untreated MMGT12 microglial cells and in cells
treated with LPS (0.01 lg/mL), IFN-g (100 U/mL), or
TNF-a (10 ng/mL) for 24 h, Notch1, Notch2, Jagged1,
and Hes1 transcripts are detected by RT-PCR. The
expression levels were affected when cells were activated
with LPS, IFN-g, or TNF-a (Fig. 2A). After 24 h, Notch1
and Jagged1 expression increased in LPS activated cells
(Fig. 2A). In contrast, Hes1 expression decreased under
the same conditions (Fig. 2A). In IFN-g or TNF-a activa-
tion, the same tendencies were observed; in addition,
Notch2 expression increased (Fig. 2A). The other genes of
the Notch family like Notch3, Notch4, Jagged2, Delta1,
and Hes5 were expressed in very low levels in microglial
cells (data not shown). Figure 2B shows that 6 h of LPS
treatment on MMGT12 microglial cells also resulted in
an increase in Notch1 mRNA as determined with real-
time RT-PCR. Showing a band at the expected molecular
weight, Western blot analysis conﬁrmed this upregula-
tion of Notch1 expression in LPS activated MMGT12
microglial cells after 24 h (Fig. 2C). The time course of
Hes1 transcription during 24 h indicates that LPS treat-
ment on MMGT12 microglial cells induced a continuous
inhibition of Hes1 mRNA as determined with real-time
RT-PCR, while Hes1 mRNA level oscillated in control
MMGT12 over 24 h (Fig. 2D). Similar results were
obtained with primary microglia (Figs. 2E,F).
These results show that the Notch pathway genes are
active in the microglial cells that their expression is
modiﬁed by activation and that Hes1 transcription is
repressed.
Fig. 1. Microglia cells express Notch1 receptor. Primary rat micro-
glial cells were grown 24 h under control (A) or LPS (0.001 lg/mL) (B)
conditions. The cells were immunostained with antibodies against
Notch1 (green). Nuclei were visualized by DAPI (blue). Scale bar: 20
lm. Insert in (B) reduced image of cells showing control staining for
nonspeciﬁc binding with an isotype control antibody. Nuclei were
visualized by DAPI (blue).
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The Notch Pathway is Functional in Microglia
Invertebrate and vertebrate Notch activation can be me-
diated by soluble forms of ligands. As mentioned earlier, we
used puriﬁed soluble rat Jagged1 as well as a secreted solu-
ble human Jagged1 from transfected cells. The addition of
Jagged1 on primary microglia resulted in morphological
changes with outgrowth of processes (data not shown).
Moreover, to conﬁrm the functional coupling of Notch
in microglia, RT-PCR was realized to show if Notch
ligands activate the expression of Notch effector Hes1.
Treatments of primary microglial cells with Jagged1
showed an upregulation of the expression of Hes1
(Fig. 3). This upregulation of Hes1 was observed in con-
trol condition as well as in the presence of LPS (Fig. 3).
The same results were obtained with MMGT12 micro-
glial cells (data not shown).
Fig. 2. Transcription of Notch-pathway genes. (A) expression analy-
sis of Notch1, Notch2, Jagged1, and Hes1 in MMGT12 microglial cells
was studied using RT-PCR. RNA extraction was realized after 24 h of
incubation. The cells were treated with either LPS 0.01 lg/mL or IFN-g
100 U/mL or TNF-a 10 ng/mL. The number of PCR cycles was deter-
mined for each primer pair: 30 cycles for Notch1 and Notch2, 32 cycles
for Jagged1, 36 cycles for Hes1, and 25 cycles for b-actin. (B) Induction
of Notch1 mRNA in MMGT12 microglial cells treated with LPS 0.01 lg/
mL after 6 h. Real-time quantitative RT-PCR results were normalized
using b-actin as a calibrator gene and are shown as average expression
fold change (with standard deviations) relative to Notch1 mRNA in con-
trol (Mean CT.ctrl.6h.Notch1 5 27.88; Mean CT.ctrl.6h.b-actin 5 15.31).
(C) Immunoblot analysis of Notch1 expression of MMGT12 microglial
cells in the absence or presence of LPS (0.01 lg/mL). (D) Inhibition of
Hes1 mRNA in MMGT12 microglial cells in the absence or presence of
LPS 0.01 lg/mL. Real-time quantitative RT-PCR results were normal-
ized using b-actin as a calibrator gene and are shown as average expres-
sion fold change (with standard deviations) relative to Hes1 mRNA in
control conditions (Mean CT.ctrl.2h.Hes1 5 26.82; Mean CT.ctrl.2h.b-
actin 5 15.71). (E) Induction of Notch1 mRNA in primary microglia
treated with LPS 0.001 lg/mL after 3 h. Real-time quantitative RT-PCR
results were normalized using b-actin as a calibrator gene and are
shown as average expression fold change (with standard deviations) rela-
tive to Notch1 mRNA in control (Mean CT.ctrl.2h.Notch1 5 29.67; Mean
CT.ctrl.2h.b-actin 5 22.52) (Mean CT.ctrl.2h. Hes1 5 32.39; Mean
CT.ctrl.2h.b-actin 5 22.54). (F) Inhibition of Hes1 mRNA in primary
microglial cells in the absence or presence of LPS 0.001 lg/mL after 3 h.
Real-time quantitative RT-PCR results were normalized using b-actin as
a calibrator gene and are shown as average expression fold change (with
standard deviations) relative to Hes1 mRNA in control conditions.
Fig. 3. RT-PCR expression analysis of Hes1 in primary microglial
cells exposed to Jagged1. RNA extraction was realized after 6 h. The
primary microglial cells were treated with LPS 0.001 lg/mL. The num-
ber of PCR cycles was determined for each primer pair: 36 cycles for
Hes1 and 25 cycles for b-actin.
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Fig. 4. Effects of Notch1 down regulation on the transcription and
release of pro-inﬂammatory cytokines. (A) RT-PCR analysis was used to
assess the regulation of Notch1, TNF-a, IL-1b, and IL-6 expression in
MMGT12 microglial cells in the presence of LPS (0.01 lg/mL) when
exposed to nonsense (NS) or antisense (AS) oligonucleotides (5 lM).
RNA extraction was realized after 6 h. The number of PCR cycles was
determined for each primer pair: 30 cycles for Notch1, 25 cycles for
TNF-a, IL-1b, IL-6, and b-actin. (B) Notch1 antisense nucleotides
increase activation-dependant TNF-a production. Antisense and non-
sense oligonucleotides (5 lM) were added to LPS-activated MMGT12
microglial cells and culture supernatants were collected after a 24 h-
incubation. TNF-a production data, obtained by ELISA are expressed
as mean 6 SEM (bars) values obtained from three experiments, each
conducted in independent cultures (n 5 3). Results are expressed as pg/
lg of total proteins. Oligonucleotides alone induce no detectable level of
TNF-a production. *P < 0.05 when comparing LPS1NS with LPS1AS.
(C) Notch1 antisense nucleotides increase activation-dependant IL-6
production. Antisense and nonsense oligonucleotides (5 lM) were added
to LPS-activated MMGT12 microglial cells and culture supernatants
were collected after a 24 h-incubation. IL-6 production data, obtained
by ELISA are expressed as mean 6 SEM (bars) values obtained from
three experiments, each conducted in independent cultures (n 5 3).
Results are expressed as pg/lg of total proteins. **P < 0.01 when com-
paring LPS1NS with LPS1AS. (D) Notch1 siRNA decreased the levels
of Notch1 transcripts in primary microglia as conﬁrmed by real-time
RT-PCR in the presence of LPS (0.001 lg/mL) after 6 h. Real-time
quantitative RT-PCR results were normalized using b-actin as a cali-
brator gene and are shown as average expression fold change (with
standard deviations) relative to Notch1 mRNA in control (Mean
CT.ctrl.6h.Notch1 5 25.08; Mean CT.ctrl.6h.b-actin 5 17.97). (E)
Notch1 siRNA slightly increased the levels of TNF-a transcripts in pri-
mary microglia as conﬁrmed by real-time RT-PCR in the presence of
LPS (0.001 lg/mL) after 6 h. Real-time quantitative RT-PCR results
were normalized using b-actin as a calibrator gene and are shown as
average expression fold change (with standard deviations) relative to
TNF-a mRNA in control (Mean CT.ctrl.6h. TNF-a 5 24.07; Mean
CT.ctrl.6h.b-actin 5 17.97). (F) Notch1 siRNA slightly increased the
levels of IL-1b transcripts in primary microglia, as conﬁrmed by real-
time RT-PCR in the presence of LPS (0.001 lg/mL) after 6 h. Real-time
quantitative RT-PCR results were normalized using b-actin as a cali-
brator gene and are shown as average expression fold change (with
standard deviations) relative to IL-1b mRNA in control (Mean
CT.ctrl.6h. IL-1b 5 22.64; Mean CT.ctrl.6h.b-actin 5 17.97). (G) Notch1
siRNA increased signiﬁcatly the levels of IL-6 transcripts in primary
microglia as conﬁrmed by real-time RT-PCR in the presence of LPS
(0.001 lg/mL) after 6 h. Real-time quantitative RT-PCR results were
normalized using b-actin as a calibrator gene and are shown as average
expression fold change (with standard deviations) relative to IL-6
mRNA in control (Mean CT.ctrl.6h. IL-6 5 29.04; Mean CT.ctrl.6h.b-
actin 5 17.97).
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These observations show that the Notch pathway is
functional in microglia and that Jagged1 induces activa-
tion of this pathway under control and under inﬂamma-
tory conditions.
Effect of Notch1 Antisense and Notch1 siRNA
Treatment on Microglial Activation
The above described results suggest a possible physio-
logical role of the Notch signaling during microglial
activation. To assess if it has functional roles in micro-
glia, antisense oligonucleotides were used to decrease
the levels of Notch1 transcripts in MMGT12 microglial
cells. The antisense oligonucleotide, designed against
the EGF repeat coding region of the mouse Notch1
gene, has previously been shown to reduce Notch1
expression in neural cells in vitro (Austin et al., 1995).
A series of oligonucleotide concentrations were tested
and it was determined that the addition of 5 lM anti-
sense oligonucleotides provided optimal inhibition with
no apparent toxicity (results not shown). All treatments
were carried out by the addition of the oligonucleotide
containing either antisense or nonsense sequences.
The treatment with antisense oligonucleotides effec-
tively downregulated Notch1 expression in MMGT12
microglial cells activated with LPS (0.01 lg/mL), when
compared with nonsense controls, conﬁrming the speciﬁc-
ity and efﬁcacy of the oligonucleotide for Notch1 (Fig. 4A).
RT-PCR realized on RNA extracts after 6 h showed
that addition of the antisense oligonucleotide to
MMGT12 microglial cells treated with LPS (0.01 lg/mL)
resulted in an increase in the production of TNF-a, IL-
1b, and IL-6 transcripts, when compared with the non-
sense control cultures (Fig. 4A). In addition, the secre-
tion by MMGT12 cells of TNF-a and IL-6 after 24 h was
measured using an ELISA. The results showed that
Notch1 antisense oligonucleotide induced an increase in
the production of TNF-a and IL-6 in activated MMGT12
microglial cells (Figs. 4B,C).
Notch1 siRNA was used to decrease the levels of
Notch1 transcripts in primary microglia. Downregula-
tion of Notch1 by siRNA transfection showed less
expression of Notch1 mRNA as conﬁrmed by real-time
RT-PCR (Fig. 4D). We have found that the downregula-
tion of Notch1 expression in primary microglia,
increased expression of IL-6 mRNA induced by LPS
treatment (Fig. 4G). The downregulation of Notch1
expression slightly increased the expression of TNF-a
and IL-1b mRNA induced by LPS treatment in primary
microglia (Figs. 4E,F).
Together these results suggest that Notch signaling
modulates the transcription of several pro-inﬂammatory
cytokines.
Notch Activation Inhibits Production of Nitric
Oxide and TNF-a in LPS-Activated Microglia
To determine whether the observed overactivation of
microglia is linked to the induced downregulation of
Notch1 expression, Notch stimulation with soluble
ligand, Jagged1, was used before LPS activation. RT-
PCR realized on RNA extract after 6 h showed that
addition of Jagged1 (1 lg/mL) to primary microglia
treated with LPS (0.001 lg/mL) resulted in a decrease
in the production of TNF-a, NOS-II, IL-1b, and IL-6
transcripts, compared to cultures treated with LPS
Fig. 5. Effects of Notch stimulation. (A) Ligand–induced Notch1
stimulation regulates the transcription levels of several genes. RT-PCR
expression analysis was used to assess the regulation of TNF-a, NOS-
II, IL-1b, and IL-6 transcription in primary microglia in the presence
of LPS (0.001 lg/mL) when exposed to Jagged1. RNA extraction was
realized after 6 h. The number of PCR cycles was determined for each
primer pair: 28 cycles for TNF-a, 31 cycles for NOS-II and IL-6, 26
cycles for IL-1b, and 25 cycles for b-actin. (B) Notch stimulation
decreases the NO production by activated microglial cells. The NO2
2
accumulation in the culture medium of MMGT12 microglial cells was
measured in the presence of LPS (0.01 lg/mL). Culture supernatants
were collected after a 48 h-incubation. NO2
2 accumulation data are an-
alyzed by a modiﬁed Griess method and expressed as mean 6 SEM
values obtained from three experiments, each conducted in independ-
ent cultures (n 5 3). Results are expressed in nmol/mL. The data are
corrected for the cell population values. *P < 0.05. (C) Notch stimula-
tion decreases the TNF-a secretion by activated microglial cells. Notch
stimulation inhibits TNF-a production by MMGT12 microglial cells in
the presence of LPS (0.01 lg/mL). Culture supernatants were collected
after a 24 h-incubation. TNF-a production was measured by ELISA
and data are expressed as mean 6 SEM obtained from four experi-
ments, each conducted in independent cultures (n 5 4). Results are
expressed in pg/mL. The data are corrected for the cell population val-
ues. **P < 0.01.
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alone (Fig. 5A). The same results were observed by RT-
PCR realized on MMGT12 microglial cells (data not
shown).
In addition, in MMGT12 microglial cells, Jagged1
treatment induced a decrease of the NO released during
the 48 h-incubation with LPS (Fig. 5B). Moreover, after
24 h of LPS exposure, a decrease in the production of
TNF-a was observed in MMGT12 microglial cells when
Jagged1 was provided (Fig. 5C). This suggests that
Notch activation downregulates the pro-inﬂammatory
cytokine-release as well as the NO production in acti-
vated microglial cells.
Notch Activation Stimulates Phagocytosis
Exposure of MMGT12 microglial cells to Jagged1 sig-
niﬁcatly increased the phagocytic activity, as assessed
by ﬂuorescent latex beads incorporation (Fig. 6). The
concentration-dependent response showed signiﬁcant
differences at 1 lg/mL of Jagged1. These data estab-
lished that the activation of Notch signaling favors
phagocytosis in microglial cells.
Notch Activation Induces STAT3 Phosphorylation
Previous reports indicated that Notch signaling cross-
talks with important pathways of inﬂammation like NF-
jB pathway and JAK-STAT signaling. Thus, it should be
possible that Notch signaling inhibits microglial activa-
tion, at least in part, by regulating the NF-jB pathway
or JAK-STAT signaling.
As expected, LPS treatment increased the level of NF-
jB p65 and phosphorylated STAT3 (phospho-STAT3)
in the nucleus of MMGT12 microglial cells. For p65
and phospho-STAT3, the peak value in the nucleus is
obtained after 30 min of LPS induction (data not shown).
Whereas p65 levels were not affected by the exposure
to Jagged1 (data not shown), phospho-STAT3 transloca-
tion to the nucleus was signiﬁcantly increased (Fig. 7).
DISCUSSION
Notch signaling is involved in multiple lineage deci-
sions in the hematopoietic system. In the lymphoid line-
age several developmental choices are regulated by
Notch. The T versus B cell lineage choice (Izon et al.,
2002; Koch et al., 2001), and the CD4 versus CD8 T cell
decision (Hadland et al., 2001) are regulated by Notch
signaling. In the myeloid lineage, Notch signaling has
been implicated in the early transition from a granulo-
cyte-monocyte progenitor to differentiated granulocyte,
although there is controversy on the exact function of
Notch in this cell lineage (Karanu et al., 2000; Tan-
Pertel et al., 2000; Walker et al., 1999).
Recently, a role for Notch signaling in fully differenti-
ated immune cells has been clearly deﬁned in macro-
phages (Monsalve et al., 2006). Resting macrophages
express Notch receptors, as well as the Notch ligands.
After treatment with LPS or IFN-g, an increase in
Notch1 and Jagged1 mRNA and protein levels is
observed. Transfection-induced over-expression of trun-
cated, active intracellular Notch1 (NICD) shows that
Notch upregulation and subsequent signaling following
macrophage activation modulate some pro-inﬂammatory
gene expression patterns known to affect the function of
mature macrophages (Monsalve et al., 2006).
In the present study, we provide ﬁrst evidence that
Notch signaling is functional in microglial cells. Here,
we show that the receptors and ligands that constitute
the Notch pathway are expressed in microglia. In our
conditions, microglial cells produce signiﬁcant levels of
Fig. 6. Phagocytic activity of microglial cells exposed to Jagged1.
Phagocytosis by MMGT12 microglial cells of ﬂuorescent microspheres
increases as a function of Jagged1 concentration (0.5 lg/mL and 1 lg/
mL). After 48 h of cell incubation, Jagged1 was added and cells further
cultured during 24 h. The microspheres were added to MMGT12 micro-
glial cells for the last hour of the incubation time. Unbound micro-
spheres were removed by washing and the ﬂuorescence was deter-
mined. Data are corrected for the cell population values and are
expressed as mean 6 SEM values obtained from three independent
experiments (n 5 3). Results are expressed relative to cultures without
treatment. **P < 0.01.
Fig. 7. Effect of Notch stimulation on STAT3 activation. Notch acti-
vation promotes STAT3 phosphorylation and nuclear translocation in
MMGT12 microglial cells exposed to LPS (0.01 lg/mL). Nuclear frac-
tions were collected after a 30 min-incubation. After binding to consen-
sus DNA binding-regions, STAT3 concentrations are obtained by ELISA
and are expressed as mean 6 SEM values obtained from three experi-
ments, each conducted in independent cultures (n 5 3). Results are
expressed as a percentage of control (100% 5 0.038 OD). *P < 0.05.
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Notch1, Notch2, and Jagged1. In these cells, the expres-
sion of the downstream target of Notch cascade, Hes1
suggests that Notch signaling is functional. Our data
show that Notch activation with soluble ligands induces
upregulation of Hes1 transcripts.
During activation with different agents (LPS, IFN-g,
TNF-a), microglial cells increase their expression of
Notch1. However, in spite of the higher expression levels
of the receptors, activated microglial cells present an
almost silenced Hes1 transcription. These unexpected
data seem to indicate that, during the activation of
microglia, some pathways interact with the Notch sig-
naling. Interestingly, stimuli that promote IjBa degra-
dation, p65 acetylation, and NF-jB activation, such as
TNF-a, inhibit Notch-dependent transcriptional activity
(Espinosa et al., 2003). Furthermore, Notch and NF-jB
pathways might compete for nuclear corepressors (Agui-
lera et al., 2004; Espinosa et al., 2002). It is interesting
to note that, in the absence of LPS, Hes1 mRNA levels
oscillate in MMGT12 microglial cells during our time
course study. These ﬁndings are consistent with observa-
tions concerning the cyclic expression of Hes1 in serum-
induced cells (Hirata et al., 2002).
The functional role of Notch in microglia is demon-
strated by an approach of modulation of Notch signaling.
In a ﬁrst step, we have decreased the expression of
Notch1. Since TNF-a, IL-1b, and IL-6 release by acti-
vated microglia are considered as markers of an active
pro-inﬂammatory response, the present results provide
evidence that decreased Notch signaling upregulates the
initiation of inﬂammation in microglia. In a second step,
the experiments of Notch activation with soluble ligand
conﬁrms the biological role of Notch signaling in micro-
glial cells, decreasing the transcription levels of NOS-II,
TNF-a, IL-1b, and IL-6 as well as the release of NO and
TNF-a. These results conﬁrm and complete those
recently reported by Monsalve et al. (2006) who show
that Notch-stimulation in peritoneal macrophages re-
duces the NO production.
Microglia fails to efﬁciently remove amyloid deposits
from the Alzheimer disease brain or its murine models.
Indeed, serial three-dimensional reconstructions of b-
amyloid plaques in an animal model of Alzheimer’s dis-
ease revealed that Ab deposits were enveloped by micro-
glial processes but were not internalized by microglia
(Stalder et al., 2001). In our hands, beta-amyloid or
LPS-activated microglial cells show a reduced phagocytic
activity (results not shown), whereas Jagged1-exposure
enhances microglial phagocytosis. It is not clear by
which mechanism the phagocytic activity is regulated in
these cells. An inhibition of the NF-jB pathway has
been shown to increase phagocytosis in macrophages
(Maiuri et al., 2004). An IL-10 induced increase in
STAT3 phosphorylation also induces an increase in
phagocytic activity (Petit-Bertron et al., 2003). As dis-
cussed below, our cells show a rise in STAT3 phosphoryl-
ation after Notch stimulation.
These experiments of inactivation or activation of
Notch signaling suggest that this pathway help to
maintain microglial cell in a quiescent state in normal
conditions and inhibits over-activation during pro-
inﬂammatory events. In CNS lesions, a re-expression of
the Notch pathway is observed (Chen et al., 2005). In
multiple sclerosis, Jagged1 is expressed at high levels
by hypertrophic astrocytes (John et al., 2002). It should
be possible that during inﬂammatory events, astrocytes
express the Notch ligand Jagged1 to stimulate micro-
glial Notch1 receptors in the lesions. In the same man-
ner, under normal conditions, neurons could be an im-
portant source of ligands for activating Notch receptor
in microglial cells. In mature cortical neurons, two
Notch ligands, Delta1 and Jagged1, are expressed
throughout the cerebral cortex and localized to neuro-
nal bodies, neurites and synapses (Sestan et al., 1999).
Thus, the re-expression of the Notch pathway, which is
regarded as detrimental for neuronal and oligodendro-
glial differentiation (Sestan et al., 1999; Wang et al.,
1998), could have beneﬁcial effects on the regulation of
inﬂammatory processes by microglia.
An important question is through which process the
Notch pathway modulates the activation of microglia. It
is conceivable that Hes1, a transcriptional repressor,
directly regulates the transcription of cytokines like
TNF-a, IL-1b, and IL-6. More likely, Notch signaling
could crosstalk with important pathways of inﬂamma-
tion like NF-jB pathway, AP-1, or JAK-STAT signaling.
Our results show that the activation of Notch signal-
ing has no effect on the NF-jB-p65 activation. This is in
agreement with ﬁndings reported by other teams (Chu
et al., 2002; Monsalve et al., 2006). Nevertheless, several
reports document an inﬂuence of the Notch pathway on
NF-jB activation (Guan et al., 1996; Oakley et al., 2003;
Wang et al., 2001). NICD could function, in a similar
way than I~jB, by interacting with the NF-jB p50 sub-
unit. Furthermore, the transcription of I~jBa is con-
trolled by RBP-J and NICD (Oakley et al., 2003). Thus,
we cannot entirely role out that interaction between the
Notch pathway and NF-jB-p50 exists.
Notch-stimulation seems to inhibit the AP-1 depend-
ant transcriptions (Chu et al., 2002; Monsalve et al.,
2006). Although the role of AP-1 appears to be less
prominent than that of NF-jB, its inhibition could also
have repercussions on the inﬂammatory behavior of
microglial cells. Further experiments are needed to shed
light on the possible interactions between the Notch and
AP-1 pathways in microglia.
STAT3 is known as a potential negative regulator of
inﬂammatory responses. STAT3 regulates innate im-
mune responses at several levels, through downregulat-
ing NF-jB activation by TLRs, through inhibiting the
growth response to cytokines such as granulocyte macro-
phage-CSF and macrophage-CSF, and through regulat-
ing an effector function of neutrophils, the NADPH oxi-
dase activity (de Jonge et al., 2005; Takeda et al., 1999;
Welte et al., 2003). Our data show an upregulation of
STAT3 phosphorylation and nuclear translocation when
Notch is activated with soluble ligand. A molecular sup-
port for these observations has been provided by recent
ﬁndings showing that STAT3 is phosphorylated after
Notch activation, as well as in the presence of the Notch
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effectors Hes1 and Hes5 (Kamakura et al., 2004). Hes
proteins associate with JAK2 and STAT3, facilitating
complex formation between these proteins, thus promot-
ing STAT3 phosphorylation and nuclear translocation.
Furthermore, suppression of endogenous Hes1 expres-
sion reduces the cytokine-dependant STAT3 phosphoryl-
ation (Kamakura et al., 2004). This mechanism could
explain the increase in nuclear phospho-STAT3 we
observe. This also sheds new light on our ﬁndings show-
ing that activated microglia express lower levels of
Hes1, thereby inducing lower phosphorylation of STAT3
and producing a more pro-inﬂammatory phenotype.
Notch-stimulation increases Hes1 expression, favoring a
higher phosphorylation of STAT3, which then correlates
with inhibition of pro-inﬂammatory events.
In conclusion, we have shown here that microglial
cells express the different components of the Notch sig-
naling pathway and that, in these cells, the Notch path-
way is functional. The results have shown that Notch
activation reduces the pro-inﬂammatory activity of
microglial cells. Our model predicts that Notch signaling
is one possible process that maintains microglial cells in
a resting state in the CNS. In normal conditions, neu-
rons express Notch ligands, thus providing the signal
capable of activating Notch in microglial cells. During
inﬂammatory events in the CNS, one role of the Notch
signaling should be to prevent an exagerated pro-inﬂam-
matory activation. Upregulation of Notch signaling is
then possible because Jagged1 is expressed at high level
in reactive astrocytes, whereas microglial cells expose
more Notch receptors at their cell surface. The data pre-
sented here reveal a new role for the Notch pathway in
the control of inﬂammation in the CNS.
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